H.P. Acthar Gel

Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit
Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit
Endpoints
Humana
insurers
Mallinckrodt
H.P. Acthar Gel
Flag link:
Mallinckrodt Halts Midstage ALS Trial Over Safety Concerns
Mallinckrodt Halts Midstage ALS Trial Over Safety Concerns
BioSpace
Mallinckrodt
ALS
clinical trials
pneumonia
H.P. Acthar Gel
Flag link:
Mallinckrodt hit with new kickback charges same day as $15.4M settlement with the feds
Mallinckrodt hit with new kickback charges same day as $15.4M settlement with the feds
Fierce Pharma
Mallinckrodt
kickbacks
whistleblower lawsuits
DOJ
H.P. Acthar Gel
Medicare
Flag link:
See you in court: Mallinckrodt takes on feds to fight $600M in back Acthar rebates
See you in court: Mallinckrodt takes on feds to fight $600M in back Acthar rebates
Fierce Pharma
Mallinckrodt
H.P. Acthar Gel
Medicaid
Flag link:
Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says
Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says
Fierce Pharma
Mallinckrodt
whistleblower lawsuits
H.P. Acthar Gel
fraud
Flag link:
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Medicare
H.P. Acthar Gel
Mallinckrodt
Remodulin
United Therapeutics
Tyvaso
Provenge
Valeant Pharmaceuticals
Gilead Sciences
Harvoni
Flag link:
5 Drugs That Are the Face of Prescription Drug Reform
5 Drugs That Are the Face of Prescription Drug Reform
Motley Fool
H.P. Acthar Gel
Mallinckrodt
Harvoni
Gilead Sciences
Orkambi
Vertex Pharmaceuticals
Isuprel
Nitropress
Valeant Pharmaceuticals
Flag link:
The top 10 most expensive drugs of 2013
The top 10 most expensive drugs of 2013
Fierce Pharma
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Flag link:
Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus
Yahoo
SLE
H.P. Acthar Gel
Questcor Pharmaceuticals
Flag link:
Companies Betting on the Next 10 Blockbuster Drugs
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Flag link:
The Curious Case Of Questcor Pharmaceuticals
The Curious Case Of Questcor Pharmaceuticals
Seeking Alpha
Questcor Pharmaceuticals
H.P. Acthar Gel
Flag link:
Why Questcor's Latest Clinical Study is a Big Deal
Why Questcor's Latest Clinical Study is a Big Deal
Motley Fool
Questcor
ARDS
H.P. Acthar Gel
Flag link:
Questcor to Start Pilot Effort for Acthar
Questcor to Start Pilot Effort for Acthar
Yahoo/Zacks
Questcor Pharmaceuticals
H.P. Acthar Gel
sarcoidosis
Flag link:
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
With $135M rights deal, Questcor locks up rival to its pricey Acthar drug
Fierce Pharma
Questcor
H.P. Acthar Gel
Novartis
Flag link:
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
NY Times
Questcor Pharmaceuticals
Synacthen
Novartis
H.P. Acthar Gel
Flag link:
Was The Aetna News Overblown? Blue Cross Blue Shield Supports Questcor's H.P. Acthar Gel
Was The Aetna News Overblown? Blue Cross Blue Shield Supports Questcor's H.P. Acthar Gel
Seeking Alpha
Aetna
Questcor Pharmaceuticals
H.P. Acthar Gel
Flag link:
Questcor: A Mid Cap Bio-Pharma With Bullish Indicators
Questcor: A Mid Cap Bio-Pharma With Bullish Indicators
Seeking Alpha
Questcor
lupus
nephrotic syndrome
infantile spasms
MS
multiple sclerosis
H.P. Acthar Gel
Flag link: